BridgeMD
New treatment option for Congenital Heart Disease in Children
Official title Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease
ClinicalTrials.gov ID: NCT06431269
What this study is testing
- What it's testing
- Feasibility and efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children aged 1 to 5 with Congenital Heart Disease
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 5
You may be able to join if
- Congenital heart disease with stable status defined by last operation \>3 months, no cardiac decompensation in the last 3 months, no planned surgery...
- Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life,
- Patient aged 1 to 5 years.
- No previous medical diagnosis of NDD
- Parental or legal guardian's consent.
You likely can't join if
- Patients with a genetic or poly-malformative syndrome with known neurological impairment.
- Neurodevelopmental disorder already known/treated
- Neurodevelopmental status evaluation within the last 6 months.
See the full eligibility criteria
- Congenital heart disease with stable status defined by last operation \>3 months, no cardiac decompensation in the last 3 months, no planned surgery within 6 months after the inclusion
- Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life,
- Patient aged 1 to 5 years.
- No previous medical diagnosis of NDD
- Parental or legal guardian's consent.
- Social security affiliation (for France only)
- Patients with a genetic or poly-malformative syndrome with known neurological impairment.
- Neurodevelopmental disorder already known/treated
- Neurodevelopmental status evaluation within the last 6 months.
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, France
- Palavas-les-Flots, France
- Pessac, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 5 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, France; Palavas-les-Flots, France; Pessac, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.